The novel thymidylate synthase inhibitor trifluorothymidine (TFT) and TRAIL synergistically eradicate non-small cell lung cancer cells

K. Azijli, I.A. van Roosmalen, J. Smit, S. Pillai, M. Fukushima, S de Jong, G.J. Peters, I.V. Bijnsdorp, F.A. Kruyt

Research output: Contribution to JournalArticleAcademicpeer-review

9 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)1273-1283
JournalCancer chemotherapy and pharmacology
Issue number6
Publication statusPublished - 2014

Cite this